Latest Updates

Select products will see a price hike of up to 15 per cent

The approved product is a generic version of Vesanoid capsules, 10 mg, of Hoffmann La Roche

Heritage study results demonstrate equivalent overall response rate for MYL-1401O in comparison to branded trastuzumab

The vaccine will protect infants from diphtheria, tetanus, whooping cough and Hib-Meningitis in India

Olmesartan medoximil tablets are used to treat high blood pressure in the US market

Sereflo, 25 mcg/125 mcg & 25 mcg/250 mcg are generic equivalent to GlaxoSmithKline’s Seretide Inhalers and are indicated for…

Odomzo has marketing approval in over 30 countries globally including US, Europe and Australia

First course from Jan 16-25, last date to apply extended to December 30

Russia-based Biosintez focuses on the hospital segment with annual revenues of about $52 million for 2015

Rubraca is a poly ADP-ribose polymerase (PARP) inhibitor to treat women with a certain type of ovarian cancer